Split History
ETFs Holding AMPE »    AMPE Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ampio Pharmaceuticals is a biopharmaceutical company focused primarily on the development of therapies to treat inflammatory conditions. Co. is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Co.'s product pipeline includes Ampion, which Co. is developing as an intra-articular injection to treat pain due to osteoarthritis of the knee; and Optina, which Co. is developing to treat diabetic macular edema. According to our AMPE split history records, Ampio Pharmaceuticals has had 1 split.
AMPE split history picture
Ampio Pharmaceuticals (AMPE) has 1 split in our AMPE split history database. The split for AMPE took place on November 01, 2004. This was a 1 for 20 reverse split, meaning for each 20 shares of AMPE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Ampio Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the AMPE split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ampio Pharmaceuticals shares, starting with a $10,000 purchase of AMPE, presented on a split-history-adjusted basis factoring in the complete AMPE split history. AMPE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2010
End date: 09/19/2017
Start price/share: $3.50
End price/share: $0.55
Dividends collected/share: $0.00
Total return: -84.29%
Average Annual Total Return: -21.93%
Starting investment: $10,000.00
Ending investment: $1,570.85
Years: 7.48
Date Ratio
11/01/20041 for 20
AMPE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AMRI Split History
AMRN Split History
AMSG Split History
ANCI Split History
ANIP Split History
ANTH Split History
APEN Split History
APHB Split History
APPY Split History
APRI Split History

Mer Telemanagement Solutions Ltd. (MTSL)
Merrimack Pharmaceuticals (MACK)
Diana Containerships Inc. (DCIX)
Farmers & Merchants Bancorp, Inc. (FMAO)
Henry Schein, Inc. (HSIC)
Intuitive Surgical, Inc. (ISRG)
Diana Containerships Inc. (DCIX)
Bridgeline Digital, Inc. (BLIN)
SUPERVALU INC. (SVU)
DryShips Inc. (DRYS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AMPE Insider Buying

AMPE Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.